BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37669100)

  • 1. Association Between Metabolic Syndrome and Mortality: Prospective Cohort Study.
    Li W; Chen D; Peng Y; Lu Z; Kwan MP; Tse LA
    JMIR Public Health Surveill; 2023 Sep; 9():e44073. PubMed ID: 37669100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of metabolic syndrome and sarcopenia with all-cause and cardiovascular mortality: a prospective cohort study based on the NHANES.
    Huang W; Deng S; Liu S; Ma Q; Cao L; Liu L; Wan H; Shen J
    Front Endocrinol (Lausanne); 2024; 15():1346669. PubMed ID: 38596221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity: an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies.
    Osadnik K; Osadnik T; Gierlotka M; Windak A; Tomasik T; Mastej M; Kuras A; Jóźwiak K; Penson PE; Lip GYH; Mikhailidis DP; Toth PP; Catapano AL; Ray KK; Howard G; Tomaszewski M; Charchar FJ; Sattar N; Williams B; MacDonald TM; Banach M; Jóźwiak J
    Eur J Prev Cardiol; 2023 Sep; 30(12):1195-1204. PubMed ID: 37039119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES).
    Oye-Somefun A; Kuk JL; Ardern CI
    BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project.
    Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z
    BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: The Japan Multi-Institutional Collaborative Cohort (J-MICC) study.
    Nguyen TV; Arisawa K; Katsuura-Kamano S; Ishizu M; Nagayoshi M; Okada R; Hishida A; Tamura T; Hara M; Tanaka K; Nishimoto D; Shibuya K; Koyama T; Watanabe I; Suzuki S; Nishiyama T; Kuriki K; Nakamura Y; Saito Y; Ikezaki H; Otonari J; N Koyanagi Y; Matsuo K; Mikami H; Kusakabe M; Takeuchi K; Wakai K
    PLoS One; 2022; 17(7):e0269550. PubMed ID: 35802721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value of metabolic syndrome and its components with respect to sudden cardiac death using different definitions: Two decades of follow-up from the Tehran Lipid and Glucose Study.
    Masrouri S; Moazzeni SS; Cheraghloo N; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Dec; 21(1):269. PubMed ID: 36463175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.
    Hunt KJ; Resendez RG; Williams K; Haffner SM; Stern MP;
    Circulation; 2004 Sep; 110(10):1251-7. PubMed ID: 15326061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
    Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
    BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and metabolic syndrome in participants of the "Seguimiento Universidad de Navarra" (SUN) cohort study.
    Pimenta AM; Lahortiga-Ramos F; Sayon-Orea C; Martínez-González MA; Sánchez-Villegas A
    J Affect Disord; 2021 Apr; 284():183-189. PubMed ID: 33607508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships among abnormal P-wave axis, metabolic syndrome and its components, and mortality in US adults.
    Wang Y; Zhang T; Zhang Y; Huang Z; Guo Q; Lan C; Deng L; Liu Y; Wu M; Yu P; Lin L; Liao Y
    J Electrocardiol; 2024 Apr; 84():137-144. PubMed ID: 38696980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and all-cause mortality in older men and women.
    Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
    Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
    Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
    Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.